Quantifying age-associated differences in the durability of Shingrix-induced immunity using mathematical modelling

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Understanding the durability of vaccine-induced immunity is critical for evaluating long-term protection and vaccine scheduling, particularly in aging populations where immunosenescence may alter immune response dynamics. In this study, we used a novel mathematical modelling pipeline to quantify age-related differences in the contraction and persistence phases of gE-specific CD4+ T cell and anti-gE antibody responses following Shingrix vaccination. Specifically, we developed a semi-mechanistic model to expand virtual populations that captured inter-individual variability in peak concentrations and waning dynamics. To compare immune responses across age groups, we introduced a time varying, age-related immune advantage metric that measures the probability of a randomly selected younger individual exhibiting a stronger immune response than one from an older group. By evaluating this metric across multiple simulated virtual populations, our results demonstrate clear and sustained age-related differences in both gE-specific CD4+ T cells and anti-gE antibody responses, with younger age groups consistently exhibiting higher responses. Given these age-related differences, we used our model to explore alternative vaccine schedules in older age groups. These exploratory simulations suggest that booster doses administered between 6 and 12 months following the second dose may mitigate age-related differences in antibody dynamics. This work highlights the use of mechanistic mathematical modelling to disentangle age-associated differences in vaccine outcomes and lead to designing of plausible improvement in age-specific vaccine schedules.

Article activity feed